About Parkwalk
Parkwalk is a venture capital firm founded in 2009. It is primarily based out of United Kingdom. As of Oct 2026, Parkwalk is an active investor, having invested in 203 companies, with 13 new investments in the last 12 months. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it participated in the $***** Seed round of Silvia Bio Overall, Parkwalk portfolio has seen 1 unicorn, 9 IPOs and 22 acquisitions including key companies like Cytora, Horizon Discovery and Tracsis. A lot of funds co-invest with Parkwalk, with names like Cambridge Enterprise sharing a substantial percentage of its portfolio. Parkwalk has team of 10 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 2 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Parkwalk's List of Top Investments
Parkwalk has a portfolio of 203 companies, one of which is a Unicorn. Their most notable investments are in Psyomics and Spectral Edge.Their portfolio spans across United Kingdom, United States, Mexico and 1 more locations. They have invested in Enterprise Applications, High Tech, Life Sciences and 30 other sectors, across stages such as Series A, Seed and 2 more. Here is the list of top investments by Parkwalk:1. BibliU
Provider of digital learning content and campus store management solutions. The platform offers institutions tools to automate content workflows and improve learning outcomes. It provides digital textbooks, monographs, and courseware. The platform integrates with existing systems to deliver an interactive learning experience. It supports diverse academic needs of students and faculty.
Key facts about BibliU
- Founded Year: 2014
- Location: Greenville (United States)
- Annual Revenue: £50M - £100M as on Oct 31, 2024
- Stage: Series C
- Total Funding till date: $102M
- Employee Count: 201 as on Aug 31, 2026
- Investors: Oxford Science Enterprises, GSP Capital and 28 Others
- Latest Funding Round: Series C, Jun 02, 2026, $*****
- Highlight: Editors' Pick
2. Cytora
Risk management solutions for insurers and underwriters. It provides risk digitization by extraction data points, risk evaluation by evaluating portfolio strategies, and more. It also allows integration of data sources, defining rules, and optimizing risk flows.
Key facts about Cytora
- Founded Year: 2012
- Location: London (United Kingdom)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $41.5M
- Employee Count: 129 as on Sep 30, 2026
- Investors: EQT, Starr Companies and 42 Others
- Latest Funding Round: Series B, Apr 17, 2019, $*****
- Highlight: Acquired
3. Nu Quantum
Developer of photonic quantum networking hardware that enables modular quantum computers to communicate through high-fidelity optical interconnects. Its networking units generate, distribute, and manage photonic entanglement to connect multiple quantum processing units (QPUs) over optical links. The company's technology enables distributed, modular quantum computing architectures and forms a key building block for future quantum data centres and the quantum internet
Key facts about Nu Quantum
- Founded Year: 2018
- Location: Cambridge (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $72.1M
- Employee Count: 97 as on Sep 30, 2026
- Investors: National Grid Partners, Start Capital and 21 Others
- Latest Funding Round: Series A, Dec 10, 2025, $*****
- Highlight: Editors' Pick
Manufacturer of niobium-based anode material for lithium-ion batteries and cells. The material enables fast charging, long cycle life, and safety for heavy-duty applications. It supplies anode active material to cell manufacturers and demonstrator cells to OEMs for evaluation. The company supports product development with its team of scientists and engineers.
Key facts about Echion Technologies
- Founded Year: 2017
- Location: Sawston (United Kingdom)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $92.4M
- Employee Count: 50 as on Mar 31, 2025
- Investors: Origin Capital, Kima Ventures and 35 Others
- Latest Funding Round: Series B, Nov 14, 2024, $*****
- Highlight: Editors' Pick
5. Oxa
Developer of autonomous software and hardware for industrial vehicle fleets. This technology enables self-driving capabilities for various industrial vehicles through modular hardware systems. The software integrates with fleet management tools to coordinate vehicle operations and logistics. These systems facilitate automated movement within industrial environments to improve operational efficiency.
Key facts about Oxa
- Founded Year: 2014
- Location: Oxford (United Kingdom)
- Annual Revenue: £1M - £10M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $349M
- Employee Count: 357 as on Sep 30, 2026
- Investors: BP Ventures, Hostplus and 26 Others
- Latest Funding Round: Series D, Mar 04, 2026, $*****
- Highlight: Editors' Pick
Parkwalk's Year-on-Year Investment Trends
Parkwalk has invested in 203 companies over the last 14 years, with an average of 6 new investments annually in the last 10 years. In 2025, it made 12 investments, while as of Oct 2026, it has made 11 investments in this year. Its most recent first time investment was in Silvia Bio.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 11 | 0 | 11 |
2025 | 12 | 0 | 12 |
2024 | 15 | 0 | 15 |
2023 | 2 | 0 | 2 |
2022 | 6 | 0 | 6 |
2021 | 1 | 0 | 1 |
2020 | 3 | 0 | 3 |
2019 | 1 | 0 | 1 |
2018 | 6 | 0 | 6 |
2017 | 3 | 0 | 3 |
Parkwalk's Investments by Stage
Parkwalk has made 25 investments in Series A stage with an average round size of $9.01M, 24 investments in Seed stage with an average round size of $3.6M, 13 investments in Series B stage with an average round size of $17.6M and 4 investments in Series C stage with an average round size of $57M.Stage of entry | No. of Investments |
|---|---|
Series A | 25 |
Seed | 24 |
Series B | 13 |
Series C | 4 |
Note: We have considered here, only first round of investments
Parkwalk's Investments by Sector
Parkwalk has a diverse portfolio, with companies operating in the High Tech, Life Sciences, Enterprise Applications, HealthTech and Semiconductors. Notably, it has invested in 180 Tech companies, 171 Enterprise (B2B) companies, 81 Software companies and at least 70 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
High Tech | 23 |
Life Sciences | 23 |
Enterprise Applications | 20 |
HealthTech | 10 |
Semiconductors | 7 |
Others | 52 |
Note: We have considered here, only first round of investments
Parkwalk's Investments by Geography
Parkwalk has made most investments in United Kingdom (64), followed by Taiwan where it has made 1 investment.Country | No. of Investments |
|---|---|
United Kingdom | 64 |
Taiwan | 1 |
United States | 1 |
Note: We have considered here, only first round of investments
Parkwalk's recent investments
Parkwalk has made 11 investments in 2026 so far. Silvia Bio and Qkine are the latest among them.Here are the most recent investments by Parkwalk:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 15, 2026 | United Kingdom | Seed | 2966 | [+1] | |
Sep 07, 2026 | United Kingdom | Series A | 6088 | ||
Jul 23, 2026 | United Kingdom | Series C | 6403 | ||
Jul 09, 2026 | United Kingdom | Seed | 7838 | [+2] | |
Jun 17, 2026 | United Kingdom | Seed | 2596 | [+3] |
Unicorns in Parkwalk's Portfolio
Parkwalk has 1 unicorn in its portfolio - Nyobolt. The most recent unicorn in their portfolio is Nyobolt which became a unicorn in 2026.Here is a list of unicorns in Parkwalk's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
57 | Developer of high power integrated energy systems for industrial applications | 2019 | Cambridge | Series C | ib{naxd |
IPOs and Publicly Listed companies in Parkwalk's Portfolio
9 of Parkwalk's portfolio companies have become public. Mirriad got listed on the London Stock Exchange (LSE), in Dec 2017 at marketcap of $85.9M and Itaconix got listed on the London Stock Exchange (LSE) at marketcap of $82.3M.Here are Parkwalk's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 19, 2017 | - | - | 1096 | |
Jul 10, 2012 | - | - | 4650 | |
Apr 11, 2011 | - | - | 7154 | |
May 14, 2010 | - | - | 4922 | |
Aug 05, 2008 | - | - | 7044 |
Acquired companies in Parkwalk's Portfolio
22 companies from Parkwalk's portfolio have been acquired. The most recent acquisition was Cytora in Sep 2025 by Applied for $*****.Here are Parkwalk's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 09, 2025 | - | - | 9570 | |
Sep 05, 2025 | - | - | 3079 | |
Sep 02, 2025 | Feb 27, 2017 | Series B | 2665 | |
Dec 19, 2024 | - | - | 4165 | |
Jul 08, 2024 | - | - | 3948 |
Team profile of Parkwalk
Parkwalk has a team of 10 members including 2 Partners and 8 Principals located in United Kingdom. Parkwalk's team sits on the board of 1 company.Here is a list of all team members in Parkwalk:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | London | - | ||
Partner | London | - | - | |
Principal | London | - | ||
Principal | United Kingdom | - | - | |
Principal | United Kingdom | - | - | |
Principal | United Kingdom | - | - | |
Principal | London | - | - | |
Principal | London | - | ||
Principal | United Kingdom | - | - | |
Principal | London | - | - |
Co-investors of Parkwalk
Over the past 14 years, 275 investors have co-invested in Parkwalk's portfolio companies. This includes funds and angels.
- Invested before Parkwalk: Parkwalk, Cambridge Enterprise and 119 others have invested in rounds before Parkwalk. There are 34 companies where Parkwalk has invested before Parkwalk and 10 companies where Cambridge Enterprise has invested before Parkwalk.
- Top Co-investors of Parkwalk: 92 investors entered a company along with Parkwalk. These include investors like Cambridge Enterprise (9 companies).
- Invested after Parkwalk: A total of 62 investors have invested in Parkwalk's portfolio after their investments. Top Investors include Ukri (3 companies), Parkwalk (3 companies) and Gov (3 companies).
Recent News related to Parkwalk
•
Quantum Motion Raises $160 Million Series C to Deliver Quantum Computing's "Transistor Moment"Financial Post•May 07, 2026•Quantum Motion, DCVC, Kembara VC, Robert Bosch Venture Capital and 5 others
